Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Magnetic resonance imaging in primary progressive multiple sclerosis.

Gordon T Ingle1, Alan J Thompson, David H Miller

  • 1NMR Research Unit, Institute of Neurology, London, United Kingdom. g.ingle@ion.ucl.ac.uk

Journal of Rehabilitation Research and Development
|June 8, 2002
PubMed
Summary

Primary progressive multiple sclerosis (PPMS) affects 10-15% of MS patients. Newer MRI techniques offer improved pathological specificity to better understand PPMS, unlike conventional MRI methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026
Same author

Long-Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy-A 10-Year Follow Up Study.

Annals of clinical and translational neurology·2026
Same author

Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis - Authors' reply.

The Lancet. Neurology·2026
Same author

Anti-Nogo-A NG101 treatment induces changes in spinal cord micro- and macrostructure following spinal cord injury.

Nature communications·2026
Same author

Performance of the 2024 McDonald Criteria in Patients Under Evaluation for Suspected Multiple Sclerosis.

Neurology·2026
Same author

Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.

Lancet (London, England)·2025

Area of Science:

  • Neurology
  • Radiology
  • Neuroimmunology

Background:

  • Primary progressive multiple sclerosis (PPMS) is a subtype of multiple sclerosis characterized by gradual neurological decline from onset.
  • PPMS patients are typically older, present with motor symptoms, and have a balanced gender distribution, differing from relapsing forms of MS.
  • Conventional MRI in PPMS often shows lower lesion loads and slower lesion formation, with a weak correlation to clinical status.

Purpose of the Study:

  • To explore the utility of advanced magnetic resonance imaging (MRI) techniques in characterizing primary progressive multiple sclerosis (PPMS).
  • To investigate if newer MRI methods can provide greater pathological specificity compared to conventional MRI in PPMS.
  • To clarify the underlying pathology of PPMS through advanced imaging.

Main Methods:

Related Experiment Videos

  • Review of studies employing advanced MRI techniques including magnetization transfer imaging (MTI), diffusion-weighted imaging (DWI), magnetic resonance spectroscopy (MRS), and functional MRI (fMRI).
  • Comparison of findings from advanced MRI techniques with conventional MRI characteristics in PPMS patients.
  • Assessment of the sensitivity of newer MRI techniques to a broader range of tissue abnormalities.

Main Results:

  • Advanced MRI techniques (MTI, DWI, MRS, fMRI) are sensitive to a wider spectrum of tissue abnormalities in PPMS.
  • These newer techniques demonstrate potential for increased pathological specificity in understanding PPMS.
  • Conventional MRI limitations in correlating imaging findings with clinical progression are noted.

Conclusions:

  • Advanced MRI techniques hold promise for a more detailed understanding of PPMS pathology.
  • Improved pathological specificity through newer MRI methods may aid in clarifying the disease mechanisms of PPMS.
  • Further research using these advanced techniques is warranted to enhance diagnostic and therapeutic strategies for PPMS.